Listed drug companies to spend 70% of net incomes for R&D.

37 local drug companies are spending 5.47% of the sales or 71.31% of net incomes for their R&D.

The KPMA reported the 2005 business performances by 37 listed drug companies as 5,717,200 million won of the total sales, 438,500 million won of net incomes (7.67% of sales) and 312,700 million won of R&D expenditures (5.47% of sales), indicating that despite a low company sales they spent more t...